Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Glioblastoma × Cisplatin × Clear all

Phase

Status

Completed 4 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 19 Squamous Cell Carcinoma of Head and Neck 10 Nasopharyngeal Carcinoma 10 Uterine Cervical Neoplasms 8 Small Cell Lung Carcinoma 6 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Esophageal Squamous Cell Carcinoma 4 Stomach Neoplasms 3 Recurrence 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Urinary Bladder Neoplasms 2 Thymoma 2 Ovarian Neoplasms 2 Nasopharyngeal Neoplasms 2 Lung Neoplasms 2 Klatskin Tumor 2 Esophageal Neoplasms 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Bile Duct Neoplasms 2 Unresectable Locally Advanced or Metastatic Solid Tumors 1 Thyroid Neoplasms 1 Thymic epithelial tumor 1 Squamous Cell Cancer of Head and Neck (SCCHN) 1 Solid Tumor Cancer 1 Sarcoma, Ewing 1 Rare Tumour 1 Pathologic Complete Response 1

Interventions

Temozolomide 11 Radiotherapy 4 Magnetic Resonance Spectroscopy 4 Blood Specimen Collection 3 Bevacizumab 3 tislelizumab 2 pembrolizumab 2 Specimen Handling 2 Radiation 2 florbetapir 1 elemene 1 contrast agent BR1 1 cemiplimab 1 X-Rays 1 Vortioxetine 1 Valacyclovir 1 Surgical Procedures, Operative 1 Spironolactone 1 Sampling Studies 1 Radiotherapy, Intensity-Modulated 1 Psychosocial Intervention 1 Platinum 1 Physical Examination 1 Photons 1 Photochemotherapy 1 Pharmaceutical Preparations 1 Lomustine 1 Haloperidol 1 Growth and Development 1 Disulfiram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07138001 2025-08-22

Phase 2 Clinical Trial of KH617

Chengdu Kanghong Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡